期刊文献+

Transarterial chemoembolization as adjuvant treatment after surgery: The cure of huge hepatocellular carcinoma? 被引量:1

下载PDF
导出
摘要 Hepatocellular carcinoma(HCC) represents the sixth common cancer and the second leading cause of cancer-related death. Its incidence is higher in Eastern countries. HCC is frequently detected at advanced stage of disease, and therefore, the mortality is high [1].
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2021年第3期205-206,共2页 国际肝胆胰疾病杂志(英文版)
  • 相关文献

参考文献5

二级参考文献65

  • 1Yifei Tan,Wei Zhang,Lunan Yan.Impact of anatomical resection for hepatocellular carcinoma with microportal invasion (vp1)[J].Hepatobiliary Surgery and Nutrition,2019,8(3):274-276. 被引量:1
  • 2Han Wang,Peng-Cheng Du,Meng-Chao Wu,Wen-Ming Cong.Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion[J].Hepatobiliary Surgery and Nutrition,2018,7(6):418-428. 被引量:29
  • 3Alexander J. Thompson,Andrew J. Muir,Mark S. Sulkowski,Dongliang Ge,Jacques Fellay,Kevin V. Shianna,Thomas Urban,Nezam H. Afdhal,Ira M. Jacobson,Rafael Esteban,Fred Poordad,Eric J. Lawitz,Jonathan McCone,Mitchell L. Shiffman,Greg W. Galler,William M. Lee,Robert Reindollar,John W. King,Paul Y. Kwo,Reem H. Ghalib,Bradley Freilich,Lisa M. Nyberg,Stefan Zeuzem,Thierry Poynard,David M. Vock,Karen S. Pieper,Keyur Patel,Hans L. Tillmann,Stephanie Noviello,Kenneth Koury,Lisa D. Pedicone,Clifford A. Brass,Janice K. Albrecht,David B. Goldstein,John G. McHutchison.Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus[J]. Gastroenterology . 2010 (1)
  • 4David Moher,Alessandro Liberati,Jennifer Tetzlaff,Douglas G. Altman.Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement[J]. International Journal of Surgery . 2010 (5)
  • 5Josep M. Llovet,Jordi Bruix.Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival[J]. Hepatology . 2003 (2)
  • 6The liver Cancer Study Group of Japan.Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan[].Cancer.1994
  • 7European Association for the Study of the Liver,European Organisation for Research and Treatment of Cancer.EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma[J].Journal of Hepatology.2012(4)
  • 8Luigi Bolondi,Andrew Burroughs,Jean-Fran?ois Dufour,Peter Galle,Vincenzo Mazzaferro,Fabio Piscaglia,Jean Raoul,Bruno Sangro.Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions[J].Semin Liver Dis.2012(04)
  • 9Josep M. Llovet,Jordi Bruix.Novel advancements in the management of hepatocellular carcinoma in 2008[J].Journal of Hepatology.2008
  • 10Marta Burrel,María Reig,Alejandro Forner,Marta Barrufet,Carlos Rodríguez de Lope,Silvia Tremosini,Carmen Ayuso,Josep M Llovet,María Isabel Real,Jordi Bruix.Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design[J].Journal of Hepatology.2012(6)

共引文献49

同被引文献13

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部